Navigation Links
Heptares to Present at Boston Biotech BD and Future Leaders in the Biotech Industry Conferences
Date:4/2/2013

WELWYN GARDEN CITY, England and BOSTON, April 2, 2013 /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery company, notes that Dan Grau (Heptares' President) will attend the Boston Biotech BD Conference taking place at the Four Seasons Hotel, Boston, MA, USA (2-3 April), at which he will participate in a panel discussion entitled Listening to Patients While Setting Company Goals: More Important than Ever? (2:00-2:30pm, 3 April).

In addition, Mr Grau will attend BioCentury's 20th Annual Future Leaders in the Biotech Industry conference taking place at the Millennium Broadway Hotel, New York City, NY, USA on Friday, 5 April, at which he will present a company overview (8:30-8:55am, Presentation Room 302/303).

For a full list of events at which Heptares will be present, please visit http://www.heptares.com

About Heptares Therapeutics Heptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, Cubist, Takeda, MorphoSys, AstraZeneca and MedImmune, and we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund and Takeda Ventures. To learn more about Heptares, please visit: http://www.heptares.com


'/>"/>
SOURCE Heptares Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
2. Heptares to Present at 5th CNS Partnering and Deal-Making Conference (13-14 SEPTEMBER)
3. Heptares and UK Medical Research Council Extend GPCR Collaboration
4. N30 Pharma Announces Presentation of Preclinical Data at the Basic Science Meeting of the European Cystic Fibrosis Society
5. KaloBios to Present at Future Leaders in the Biotech Industry Conference
6. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
7. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
8. Regulus to Present at Future Leaders in the Biotech Industry Conference
9. Chimerixs Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantations Annual Meeting
10. Inovio Pharmaceuticals to Present at BioCenturys "Future Leaders in the Biotech Industry" Conference
11. Howard Leonhardt to Present 25 Years of Experience With Stem Cell Transplantation at 28th Annual Interventional Cardiology Conference in Snowmass, Colo., on March 28
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Horizon Blue Cross ... the company’s credit rating of “A” and its outlook as “stable.” At the same ... reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required for ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: April ... “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on her ... Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she was ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
Breaking Medicine News(10 mins):